MK-677 (Ibutamoren): What It Is and How It's Used in the Philippines

Quick read: MK-677 is an oral ghrelin mimetic that elevates GH and IGF-1 for 24+ hours per dose. Dosed at 10-25mg daily, it's used for bulking, sleep depth, appetite stimulation, and recovery. In PH, it's popular among male lifters for mass-building phases, but side effects (water retention, increased appetite, lethargy, insulin resistance risk) make it less suitable for cuts.

What it is

MK-677 (also called Ibutamoren or Nutrobal) is an oral compound that mimics ghrelin, the hunger hormone. It binds to ghrelin receptors and triggers sustained GH and IGF-1 elevation for 24+ hours.

It's technically not a peptide (it's a small molecule), and it's not a SARM (selective androgen receptor modulator), but it's commonly grouped with both in the research compound community.

The key advantage over injectable GH secretagogues (Ipamorelin, CJC-1295) is oral administration. The downside is less selectivity: MK-677 elevates GH/IGF-1, but also increases cortisol, prolactin, and appetite more than injectable GHRPs.

Research shows MK-677 significantly increases GH and IGF-1, improves sleep depth, and increases lean body mass in elderly populations. It's been studied for muscle wasting, bone density, and growth hormone deficiency.

In the PH peptide community, MK-677 is used primarily by male lifters during bulking phases. The appetite stimulation is seen as an advantage for mass-building, but a disadvantage during cuts.

What it's used for

Primary use: Bulking and mass-building. MK-677's appetite stimulation makes it easier to eat in a caloric surplus. Elevated GH/IGF-1 supports muscle growth and recovery.

Secondary use: Sleep depth and recovery. MK-677 significantly improves slow-wave sleep, which supports recovery and GH release.

Tertiary use: Injury recovery and joint health. Elevated GH/IGF-1 supports soft tissue healing and collagen synthesis.

Realistic expectations: Users running MK-677 for 12-16 weeks during a bulk typically gain 2-5kg of lean mass, along with water weight and some fat (due to increased appetite). Sleep quality improves noticeably.

Typical protocols

Bulking protocol:

• Dose: 15-25mg oral daily
• Timing: Before bed (to align with natural GH pulse and mitigate daytime lethargy)
• Duration: 12-16 weeks

Conservative protocol (first-time users):

• Dose: 10mg daily
• Duration: 8 weeks

Sleep/recovery protocol:

• Dose: 10-15mg before bed
• Duration: Ongoing or as-needed

Timing: Before bed to capitalize on sleep-enhancing effects and avoid daytime lethargy and hunger.

What users typically report

Week 1-2: Sleep depth improves dramatically. More vivid dreams. Hunger increases significantly (within hours of dosing). Some users report lethargy or grogginess during the day.

Week 3-8: Continued hunger and sleep improvement. Weight increases (combination of muscle, water, and fat). Strength may improve. Skin quality may improve (due to elevated GH).

Week 9-16: Effects plateau. Water retention may become more pronounced. Some users report joint aches or numbness/tingling (similar to exogenous GH).

Variance: Response is individual. People who struggle to eat enough calories for bulking tend to love MK-677. People trying to cut hate it due to relentless hunger.

Common side effects

Increased appetite (50-70%): Significant and persistent hunger. This is an advantage during bulks, but makes cutting nearly impossible.

Water retention (30-50%): Bloating, especially in the face and hands. More pronounced at higher doses.

Lethargy and grogginess (20-30%): Especially during the first few weeks or if dosed during the day.

Joint pain (10-20%): Similar to exogenous GH, related to water retention and elevated IGF-1.

Insulin resistance risk (documented in research): Long-term MK-677 use (6+ months) can worsen insulin sensitivity and elevate fasting glucose.

Elevated prolactin (documented): Can lead to gynecomastia (breast tissue development) in susceptible users.

Serious side effects: Prolonged insulin resistance, potential for worsening prediabetes or metabolic syndrome.

Side effect management

Increased appetite: Embrace it during bulks. Avoid MK-677 during cuts.

Water retention: Reduce sodium intake. Increase water consumption. If severe, reduce dose.

Lethargy: Dose before bed. Avoid daytime dosing.

Joint pain: Reduce dose. Ensure adequate potassium and magnesium.

Insulin resistance: Monitor fasting glucose and HbA1c. If glucose rises significantly, stop. Consider metformin for glucose management (if prescribed).

Elevated prolactin: Check prolactin levels via bloodwork. If elevated, consider cabergoline (if prescribed) or discontinue MK-677.

Who this compound is for

MK-677 is for male lifters during bulking phases who want appetite stimulation, sleep improvement, and GH/IGF-1 support. It's popular in PH male lifting culture for mass-building.

It's also appropriate for older users (40+) who want to improve sleep and recovery without daily injections.

Who this compound is NOT for

People trying to lose fat: The appetite stimulation makes cutting miserable.

People with insulin resistance, prediabetes, or diabetes: MK-677 can worsen glucose metabolism.

People with elevated prolactin or gynecomastia: MK-677 can worsen these conditions.

Pregnancy/breastfeeding: No safety data.

PH-specific considerations

Bulking culture in PH male lifters: Manila's lifting culture (esp. younger men, 20s-30s) often emphasizes mass-building. MK-677 fits this demographic.

Appetite stimulation as advantage or disadvantage: For users who struggle to eat enough (common in naturally lean Filipino men), MK-677 is a game-changer. For users trying to cut, it's torture.

Cost: MK-677 is relatively affordable and oral, which makes it accessible.

Insulin resistance concerns: The "skinny-fat" phenotype (low muscle, high visceral fat, insulin resistance) is common in PH. MK-677 may worsen insulin sensitivity, making it less suitable for this demographic.

Common stacks

MK-677 + CJC + Ipamorelin: For synergistic GH elevation. Protocol: 15mg MK-677 before bed + 100mcg CJC + 200mcg Ipa before bed. Note: This creates significant GH elevation and side effect risk increases.

MK-677 + BPC-157 + TB-500: For injury recovery and mass-building simultaneously.

Avoid MK-677 during GLP-1 protocols: The appetite stimulation from MK-677 directly opposes the appetite suppression from GLP-1 agonists.

Things to watch

Bloodwork baseline (before starting):

• Fasting glucose, HbA1c
• IGF-1
• Prolactin
• Lipid panel

Week 6-8 recheck:

• Fasting glucose (watch for insulin resistance)
• IGF-1 (ensure not excessively elevated)
• Prolactin (if gyno symptoms appear)

Week 12+:

• Fasting glucose, HbA1c
• IGF-1

Subjective metrics:

• Sleep quality
• Appetite
• Body weight (weekly)
• Strength

Red flags:

• Fasting glucose rising significantly
• Gynecomastia symptoms (puffy nipples, breast tissue)
• Persistent joint pain or numbness

Coming off / cycling

MK-677 does not require a taper. Stop cold after completing your cycle.

Timeline after stopping:

• Week 1-2: Appetite returns to baseline or below (rebound suppression is common)
• Sleep quality may dip slightly
• Water weight drops quickly (1-3kg within days)

Cycling approach: Most users run MK-677 for 12-16 weeks during bulks, then cycle off for 8-12 weeks. Continuous use beyond 6 months increases insulin resistance risk.

---

Related compounds

• Ipamorelin — Injectable GHRP, cleaner side effect profile than MK-677
• CJC + Ipamorelin — Injectable GH stack, alternative to MK-677
• Tesamorelin — GHRH analog for visceral fat, opposite use case from MK-677

Sources

• Murphy 2001 — MK-677 effects on GH and IGF-1 elevation
• Nass 2008 — MK-677 for elderly patients, lean mass and bone density
• Svensson 1998 — MK-677 and insulin sensitivity concerns

---

Last updated: 2026-05-20. This page is for educational purposes and does not constitute medical advice. Always consult a qualified healthcare professional before starting any peptide protocol.